WYETH (WYE) 50.39 $0.00 (0.00%) 10:58AM (15 mins delay)

WYE

$50.39 $0.00 (0.00%)

You need to upgrade your Flash Player

Today

10y

Last:	$50.39	High:	-
Prev Close:	$50.39	Low:	-
Open:	-	Mkt Cap:	N/A
Change:	$0.00 ( 0.00% )	52Wk High:	$50.45
Vol:	0	52Wk Low:	$30.71
Avg Volume:	6,763,419	Shares:	1335.05B
EPS:	3.38	PE Ratio:	14.91

Start trading WYE with real money!

Company Description

The Company is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of products in three primary businesses: Pharmaceuticals, Consumer Healthcare and Animal Health.

	MadMoneyOnCNBC via Twitter	Nov 02 10:07 PM
	A Cure for Cancer? http://cnbc.com/id/335887.. $BMY $MJN $PFE $WYE #StockPicks #StockMarket Comment

	SEC Watch via Twitter	Oct 28 5:34 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/3kw09U Comment

	SEC Watch via Twitter	Oct 27 1:22 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/45vg2s Comment

	SEC Watch via Twitter	Oct 27 1:20 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/4o5GQf Comment

	SEC Watch via Twitter	Oct 27 1:18 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/48bucz Comment

	SEC Watch via Twitter	Oct 27 1:15 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/2LzuaN Comment

	SEC Watch via Twitter	Oct 27 1:07 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/1m9agp Comment

	SEC Watch via Twitter	Oct 27 12:46 PM
	$WYE files form S-8 POS(Post-effective amendment to a S-8 registration statement) http://bit.ly/1EkPXE Comment

WYETH (WYE) Stock News & Analysis

	Healthcare Profits: Assessing Company Sensitivity to Obamacare	10/30/2009
	TIM Report: Profit Taking Results in Less Bullish Market Sentiment	10/26/2009
	Galleon Group's 50 Largest Holdings	10/18/2009
	ISCTM Meeting Discusses Clinical and Regulatory Aspects of Using Adaptive Designs in Clinical Trials for Central Nervous System Drug Approvals	10/15/2009
	GVK Biosciences is the Winner of the European Outsourcing Award 2009 for Best New Partnership along with Wyeth Research	10/15/2009
	SmartOps and Wyeth Consumer to Present at SAP(R) World Tour 2009	10/15/2009
	Wednesday Options Recap	10/14/2009
	Progenics: Investors Are Right To Be Wary	10/14/2009
	Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet	10/12/2009
	New Data From the PRESTA Trial Demonstrate the Benefit of Enbrel(R) in Patients With Psoriasis and Psoriatic Arthritis	10/09/2009
	SmartOps Announces Record Attendance at Forum 2009	10/08/2009
	New 52 Week Highs: Coca Cola, Wyeth	10/06/2009
	Tuesday Options Update: NTRI, GFI, AUY, AA, & WYE	10/06/2009
	China Biotech Week in Review: Wyeth / Pfizer Merger Allowed	10/04/2009
	China Requires One Divestiture for Pfizer / Wyeth Merger	10/01/2009

View all

Write Your Own Stock Analysis

Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.

New WYE Stock Picks

	news @ 1:30 today
Posted 464 days ago on 7/30/08		by xxxAPxxx

	ANTI-ALZHEIMER'S DRUG SUCCESS
Posted 577 days ago on 4/08/08		by Lex Saba

	in the pipeline
Posted 578 days ago on 4/07/08		by Cindy Peel

	Possible M/A
Posted 584 days ago on 4/01/08		by Matt Jensen

	WYE a decent buy and hold
Posted 585 days ago on 4/01/08		by bjprat

View all

WYETH (WYE) 50.39 $0.00 (0.00%) 10:58AM (15 mins delay)

WYE

$50.39 $0.00 (0.00%)

Company Description

What do you think about WYE?

Comments on WYE

WYETH (WYE) Stock News & Analysis

Write Your Own Stock Analysis

New WYE Stock Picks

WYETH (WYE) 50.39 $0.00 (0.00%) 10:58AM (15 mins delay)

WYE $50.39 $0.00 (0.00%)

Company Description

What do you think about WYE?

Comments on WYE

WYETH (WYE) Stock News & Analysis

Write Your Own Stock Analysis

New WYE Stock Picks

WYE

$50.39 $0.00 (0.00%)